长寿科学，作为高端美妆品牌的未来命题，已经进入了产业化落地的关键期。国内外各大品牌 都用实际行动押注这一领域，并努力在长寿科学领域探索可行的落地方式。 同样，这也是一场长寿科学的话语权之争，谁先给出切实可行的解决方案，就可以定义未来长 寿科学产业化"游戏规则"。 作为这场新兴趋势的发起者和先驱品牌，雅诗兰黛以1 5多年积淀为根基，持续引领肌肤长寿科 学的风向——从全球科研突破迭代、长寿圣地溯源，到产品矩阵落地、线下体验升级，每一步 皆为肌肤长寿科学理念的深度解构与实践进阶，定义科学逆龄新范式。 一直以来，长寿科学是一个体系庞大、多学科、多产业交融的体系，因其相关研究过于超前， 其产业化在行业中还鲜少有可参照的案例。在品牌层面，许多品牌对长寿科学的理解尚停留在 成分层面。 作为长寿科学领域的先驱者，雅诗兰黛在肌肤长寿科学的产业化实践上已经领先多个身位。 近日，雅诗兰黛「肌肤逆龄中心」在中国市场迎来第一轮落地，雅诗兰黛「肌肤逆龄中心」率 先登陆北京SKP和南京德基广场两大一线高奢地标商圈。 雅诗兰黛北京SKP「肌肤逆龄中心」 据了解，雅诗兰黛通过「肌肤逆龄中心」的AI肌肤检测+黑钻精雕逆龄SPA、光氧疗愈空间与 ...

中基长寿科学(00767)发布公告，于2025年9月13日，本公司的间接非全资附属公司中骊(海南)生命科学 技术有限公司(中骊海南)与海南博鳌超级医院有限公司(海南博鳌)签署合作协议(合作协议)，中骊海南与 海南博鳌双方共同建立"国际肿瘤精准医学中心"(医学中心)，海南博鳌负责提供中心的场地及提 供"1+X"平台的服务功能，包括但不限于：门诊、住院、检查、治疗、手术等，中骊海南负责中心的营 运并提供专家及专科技术和专科设备支援，双方共同为患者开展诊疗活动及各种科研项目。 董事会认为健康长寿科学市场的前景广阔，因为观察到全球的富裕客户更愿意接受及花费在长寿科学应 用上，以提升彼等的整体健康及免疫状况，并促进彼等身体年轻化。 签署合作协议符合本集团的长寿科学业务发展策略及计划，将有利于本集团未来的业务发展，为本集团 进一步拓展国内市场奠定了坚实的基础。董事会相信签署合作协议进一步完善本集团在长寿科学诊断及 医疗服务领域的布局，为本集团开拓新的长寿科学收入来源，以期长远为本集团带来更加稳定及持续增 长的收入。 ...

签署合作协议符合本集团的长寿科学业务发展策略及计划，将有利于本集团未来的业务发展，为本集团 进一步拓展国内市场奠定了坚实的基础。董事会相信签署合作协议进一步完善本集团在长寿科学诊断及 医疗服务领域的布局，为本集团开拓新的长寿科学收入来源，以期长远为本集团带来更加稳定及持续增 长的收入。 董事会认为健康长寿科学市场的前景广阔，因为观察到全球的富裕客户更愿意接受及花费在长寿科学应 用上，以提升彼等的整体健康及免疫状况，并促进彼等身体年轻化。 智通财经APP讯，中基长寿科学(00767)发布公告，于2025年9月13日，本公司的间接非全资附属公司中 骊(海南)生命科学技术有限公司(中骊海南)与海南博鳌超级医院有限公司(海南博鳌)签署合作协议(合作 协议)，中骊海南与海南博鳌双方共同建立"国际肿瘤精准医学中心"(医学中心)，海南博鳌负责提供中心 的场地及提供"1+X"平台的服务功能，包括但不限于：门诊、住院、检查、治疗、手术等，中骊海南负 责中心的营运并提供专家及专科技术和专科设备支援，双方共同为患者开展诊疗活动及各种科研项目。 ...

Group 1 - The company, Zhongji Changshou Science (00767.HK), has signed a cooperation agreement with Hainan Boao Super Hospital to establish an "International Precision Medicine Center for Oncology" [1] - Hainan Boao will provide the center's facilities and services, while Zhongji Changshou will manage operations and provide expert support and specialized equipment [1] - The Boao Super Hospital is recognized as a pioneer in China's medical field, leveraging special policies to utilize advanced foreign medical technologies and services [1] Group 2 - The board believes that the market for longevity science is promising, as affluent clients are increasingly willing to invest in longevity applications to enhance their health and vitality [2] - The cooperation agreement aligns with the company's strategy for developing longevity science, laying a solid foundation for future business expansion in the domestic market [2] - The agreement is expected to enhance the company's positioning in the longevity science diagnostic and medical service sectors, creating new revenue streams for stable and sustainable growth [2]

" 长寿正逐渐成为现实 。 "欧莱雅北亚研发和创新中心副总裁容德明不无激动地表示，在生命 科 学 、 AI 等 技 术 等 推 动 下 ， 整 个 人 类 社 会 正 迎 来 一 场 全 新 的 长 寿 革 命 ——" 当前，我们仍处 于'长寿科学'的探索初期。 " 而 伴 随 " 长 寿 时 代 " 的 到 来 ， " 美 " 的 势 能 也 在 经 历 重 塑 ， 欧 莱 雅 集 团 开 创 性 地 在 全 球 发 起 了"Th e Be a u t y o f Lo n g e v it y "（中文名：新龄美）项目。 欧莱雅北亚研发和创新中心副总裁容德明 2 0 2 5年7月1 2日，在上海举办的全球抗衰老与医美科学顶级学术会议——IMCAS英卡思大会 上，欧莱雅集团首次向中国市场揭开「新龄美」的全貌，这一涵盖科学健康、重塑认知和文化 经济三个维度的项目，革新传统长寿理念，引领一场前所未有的范式变革。 " 美不分年龄，是所有人都可以选择的一种生活方式。我们要做的，是构建全周期的美。 " 欧 莱雅北亚及中国公共事务总裁兰珍珍把「新龄美」生动比喻为一棵生命之树， 科学健康 是它 扎根土壤的根须， 文化观念 ...

Core Viewpoint - Zhongji Changshou Science (00767) has entered into a memorandum of cooperation with Haoshiduo (Shenzhen) Biotechnology Co., Ltd. to collaborate on longevity detection and management services, aiming to provide longevity-related products and health consultation services in the health industry [1][2] Group 1 - The cooperation will involve Zhongji Changshou's subsidiary, Hongfeng Development, providing product services and management system support, while Haoshiduo will supply domestic customer resources and market sales channels [1] - Haoshiduo is an innovative biotechnology company engaged in health, biotechnology research and development, and artificial intelligence application software development, with strong customer base and market expansion capabilities [1] - The board believes that the health and longevity science market has broad prospects, as wealthy customers globally are increasingly willing to invest in longevity science applications to enhance their overall health and immune status [1] Group 2 - The memorandum aligns with the group's strategy for developing longevity science business and is expected to benefit future business growth [2] - The board is confident that the cooperation will enhance the group's layout in the longevity science diagnostics and medical services sector, opening new revenue sources in longevity science [2] - The aim is to achieve more stable and sustainable revenue growth for the group in the long term [2]

Core Viewpoint - Zhongji Longevity Science (00767) has signed a memorandum of cooperation with Haoshiduo (Shenzhen) Biotechnology Co., Ltd. to collaborate on longevity detection and management services, aiming to provide longevity-related health products and services [1][2] Group 1: Cooperation Details - The cooperation involves Zhongji's subsidiary, Hongfeng Development, providing product services and management system support, while Haoshiduo will supply domestic customer resources and market sales channels [1] - Haoshiduo is an innovative biotechnology company engaged in health, biotechnology research and development, and AI application software development, with strong market capabilities and brand promotion [1] Group 2: Market Outlook - The board believes the health longevity science market has significant potential, as affluent customers are increasingly willing to invest in longevity applications to enhance their overall health and immune status [1] - The memorandum aligns with the group's longevity science business development strategy, which is expected to enhance the company's positioning in the longevity science diagnostics and medical services sector, creating new revenue streams for stable and sustainable growth [2]

Group 1 - The company, Zhongji Changshou Science, has signed a memorandum of cooperation with Haoshiduo Biotechnology to collaborate on longevity detection and management services [1] - The partnership aims to provide longevity biological products, medical testing, health consulting services, and management solutions within the health industry [1] - The company operates through its subsidiary, Hongfeng Development, which focuses on longevity science research, medical testing, biological products, and management [1] Group 2 - The board believes that the health and longevity science market has significant potential, as affluent customers are increasingly willing to invest in longevity applications to enhance their overall health and immune systems [2] - The memorandum aligns with the company's strategic development plan in the longevity science sector, which is expected to benefit future business growth [2] - The collaboration is anticipated to enhance the company's positioning in the longevity science diagnostics and medical services field, creating new revenue streams for long-term stable growth [2]

Group 1 - The company, Zhongji Changshou Science, announced a joint venture agreement with Huali (Guangdong) Life Science Technology Co., Ltd. to establish a joint venture in China, with Zhongji Health holding 51% and Huali Life holding 49% of the equity [1] - The initial registered capital of the joint venture is set at RMB 1 million, which will be contributed by both parties according to their respective equity ratios [1] - The joint venture aims to provide longevity health services in China, capitalizing on the growing demand from affluent customers willing to invest in longevity science applications to enhance their overall health and immune status [1] Group 2 - The establishment of the joint venture aligns with the company's strategic development plan in the longevity science sector and is expected to benefit future business growth [2] - The joint venture will create a leading life science industry empowerment platform, integrating academic conferences, technology transfer, and industrial implementation into a cohesive ecosystem [2] - The board believes that the joint venture will enhance the company's positioning in the longevity science diagnostics and medical services field, opening new revenue sources for long-term stable and sustainable growth [2]